Kraig Biocraft Laboratories Implements Innovative Protocol for Advanced Fiber Quality Control
July 30 2014 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, announces
that research scientists who are working as consultants for the
Company have recently implemented a new materials analysis protocol
to further improve the quality of the Company's genetically
engineered spider silk based fibers.
The scientists tested the new procedures and are now using them
to test individual fiber filaments. The innovation allows Kraig to
gather testing data on its transgenics even before the transgenics
reach the stage where they are spinning cocoons. This early
testing data is then incorporated into the decision making process,
regarding artificial selection and selective breeding. The new
process means the research team can assess, and then make
adjustments to variations in, the silk colony, reduce variability,
and, the Company believes, further increase the quality of its
recombinant fiber production.
"One of the biggest issues we have faced, as we focus on moving
our materials to market, is natural variability between individual
fiber filaments. This new protocol and procedure is a
significant breakthrough that will allow us to improve quality,
while reducing variability. Overcoming this major hurdle has a
direct impact in the laboratory and the commercial ramp up
program," said Company founder and CEO, Kim K. Thompson. "I want to
thank the scientists who have implemented and are perfecting this
protocol, which we believe will have a real impact on our
commercialization program." Thompson concluded.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Sep 2023 to Sep 2024